CABG or stents?
Compare what fits your case.

There is no single answer for every patient. The comparison depends on coronary anatomy and complexity, left-main or multivessel disease, diabetes, heart function, symptoms, prior procedures, procedural risks, expected durability, medication considerations, and patient priorities. The review explains how the documented factors in your record shape the discussion without assuming one option is always superior.

Important factors may include which vessels are diseased, lesion location and complexity, whether the left main or several vessels are involved, diabetes, left-ventricular function, kidney disease, bleeding or stroke risk, prior stents or surgery, completeness of revascularization, and the outcomes and burdens that matter most to you.

For an appropriate surgical candidate with diabetes and multivessel coronary disease involving the LAD, current professional guidance generally favors CABG over PCI. PCI can still be useful when surgery is a poor fit. The useful comparison also considers anatomy, heart function, procedural risks, other health conditions, technical feasibility, and personal priorities.

Significant left-main disease is a high-stakes finding. Current professional guidance supports CABG to improve survival compared with medical therapy; PCI can be a reasonable alternative in selected patients when it can provide revascularization comparable to CABG, while high-complexity anatomy generally favors surgery. The lesion, remaining anatomy, heart function, procedural risks, technical feasibility, and patient circumstances still require multidisciplinary interpretation and shared decision-making.

When it applies and the necessary inputs are available, the review considers the current STS Adult Cardiac Surgery Database operative-risk estimate, its verified inputs and calculation date, and makes missing inputs and model limitations visible. The STS estimate applies to surgical risk only and may not fully capture factors such as frailty. PCI-related considerations may include bleeding, stroke, kidney, vascular, contrast, and antiplatelet-therapy factors documented in the record. Other scores are discussed only when documented in the source record. No estimate predicts an individual outcome with certainty.

PCI often involves a shorter initial recovery, while CABG generally requires a larger recovery commitment. Longer-term considerations can include completeness and durability of revascularization, graft or stent performance, the possibility of repeat procedures, and ongoing medication needs. The report puts those trade-offs in the context of your specific record.

Guideline-directed medical therapy, lifestyle measures, and risk-factor management remain foundational whether the plan is CABG, PCI, or no procedure. PCI commonly requires clinician-directed antiplatelet therapy; the regimen and duration depend on whether the presentation is acute or chronic, ischemic and bleeding risk, and procedure factors. Difficulty accessing, tolerating, or adhering to dual antiplatelet therapy may favor CABG when both procedures are otherwise feasible. The review organizes the medications, contraindications, and practical considerations documented in your case for discussion with your treating clinicians.

A cardiac surgeon and cardiologist independently review the same record set, then confer and co-sign one patient-facing WHITEGLOVE Insights™ report. Their two clinical perspectives are included in both plans.

After your complimentary conversation, we email the package we recommend, what it includes, and the secure next step. The written review includes two independent physician reviews and a co-signed written report; higher service levels add a live consultation. WHITEGLOVEMD is a direct-pay service and does not submit insurance claims.

The report is delivered within 24 hours only after all required records and imaging are received and confirmed complete. Time spent gathering missing records is outside the 24-hour window. The records team can help identify and gather what is needed with your authorization.

No referral or travel is required for the written medical-record review. You may choose the written review alone or a higher tier that also includes one live consultation with one reviewing physician.

No. WHITEGLOVEMD provides a limited-scope independent medical-record review. It does not provide emergency or ongoing treatment, order tests or medications, or replace the clinicians responsible for your care. The reviewing physicians’ role is defined in the consent and service terms.